ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy.
J Transl Med
; 21(1): 605, 2023 09 07.
Article
in En
| MEDLINE
| ID: mdl-37679788
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Esophageal Neoplasms
/
Esophageal Squamous Cell Carcinoma
Limits:
Humans
Language:
En
Journal:
J Transl Med
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido